A pilot study on use of live attenuated rotavirus vaccine (Rotarix™) as an infection challenge model. (2020)

First Author: Chilengi R
Attributed to:  Human infection challenge vaccine (HIC-vac) network funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2020.09.023

PubMed Identifier: 33032844

Publication URI: http://europepmc.org/abstract/MED/33032844

Type: Journal Article/Review

Volume: 38

Parent Publication: Vaccine

Issue: 46

ISSN: 0264-410X